Pueraria Mirifica "builds up the breast enhancement - produces hormone in menopause" A committee is appointed to study Pueraria mirifica. It is reportedly found to be efficient in building up the breast enhancement and working as a substitute hormone in Menopause women. The government sector is ready to revise the law for Pueraria mirifica to be a dietary reinforcement product. The result is expected to be known in 3 months.

Bangkok Thailand 12/9/2005

The Deputy Minister of Public Health, has said that a meeting of the working group considering Pueraria mirifica, which consister of a group of researchers from Chulalongkorn University, the National Cancer Institute, the Institute of Dermatology, the Department of Medical Sciences, Mae Fa Luang University, etc., was held to determine whether or not it would be possible to promote Pueraria mirifica production as a topping industry for commercialized distribution, as a conclusion of which a national-level committee was set up to be in charge of pushing Pueraria mirifica, with Mrs. Khrueawan Somana, acting as the chairman of the working group for revising the law, since it lags far behind the laws of other countries. The meeting also arrived at a conclusion that Pueraria mirifica is clinically efficient in working as a substitute in menopause women and there is a trend that it will be used to build up the breast enhancement and to cure Alzheimer’s disease by generating a regrowth of cells.

As regards toxicity, there is a conclusion from the National Cancer Institute that Pueraria mirifica is non-carcinogenic and this conforms to a research finding of King Mongkut’s Hospital that Pueraria mirifica can also prevent cancer, so there came a conclusion that a national-level committee be set up to be in charge of pushing Pueraria mirifica, which will consider from research at a clinical and the revision of the medicinal herb law,

The patent question was extensively discussed, because there is already a case of patent registration by a Thai. In fact, that is a patent registration seeking to concoct Pueraria mirifica as an ancient intellectual background. The focus at this moment is a process of turning the effective substance in Pueraria mirifica into a standard product and taking the process to register a patent, which a representative of the Department of Intellectual Property will be invited to joint in considering, and where possible, the patent will also be registered aboard.

Prof. Dr. Urusa Thepphisai, a researcher from Ramathibodi Hospital, as saying that Pueraria mirifica is registered as a traditional drug under the Drug Act, while in the United States of America Europe and Japan it is dietary reinforcement product. Food and Drug Administration and the Institute of Thai Traditional Medicine

Call on the media to contact you

Contact Anchalee S. for more information regarding this award. Direct line:
66-76- 218212 Email: info@phuketherb.com Other helpful information regarding the award can be found at: www.phuketherb.com.

For More Information Contact:

Anchalee S.
info@phuketherb.com
www.phuketherb.com

This release was published on openPR.